Skip to Main Content
An official website of the United States government

Use of Radiomics and AI To Predict Malignancy in Indeterminate Lung Nodules

Principal Investigator

Name
Richard Lee

Degrees
MBBS MRCP MA (Cantab) PhD

Institution
The Royal Marsden Hospital

Position Title
Consultant Respiratory Physician, Early Diagnosis Champion, RM Partners Lung Pathway Chair

Email
richard.lee@rmh.nhs.uk

About this CDAS Project

Study
NLST (Learn more about this study)

Project ID
NLST-593

Initial CDAS Request Approval
Nov 19, 2019

Title
Use of Radiomics and AI To Predict Malignancy in Indeterminate Lung Nodules

Summary
Indeterminate lung nodules require interval imaging to assess cancer risk, which generates anxiety for patients and places a significant resource-burden on the National Health Service.
A proportion of patients who score highly on existing risk models, such as those with large (>15mm) nodules, will have negative biopsies, and there is a need to improve patient stratification.
We have previously developed radiomics algorithms to predict the risk of malignancy in incidental lung nodules, but these have not been tested in cohorts of exclusively larger nodules.

A retrospective clinical database of lung nodule patients investigated at the Royal Brompton Hospital has been developed, which will be used to test the accuracy of our existing tools in predicting malignancy in 15-30mm nodules, as well as to develop novel radiomics and AI approaches in this setting. Existing lung-nodule datasets, such as the NLST data, will be used to validate our predictive models.

Aims

1) To establish an anonymised retrospective database of clinical information and scan images from patients investigated for lung nodules nodules at the Royal Brompton Hospital and other sites across the London Cancer Alliance.

2) To use this database to create novel radiomics algorithms to predict the risk of malignancy in both large (>=15mm) and small (<15mm) nodules.

3) To validate these algorithms in independent cohorts, including the NLST dataset.

Collaborators

Professor Eric Aboagye, Professor of Cancer Pharmacology and Molecular Imaging, Imperial College London.

Professor Anand Devaraj, Consultant Radiologist, The Royal Brompton and Harefield NHS Foundation Trust.

Dr. Benjamin Hunter, Clinical Research Fellow, The Royal Marsden NHS Foundation Trust.